Paul Hastings·FDA / LIFE SCIENCES REGULATORY
SEC-FDA MOU establishes new inter-agency cooperation framework
The SEC and FDA announced a memorandum of understanding to coordinate on market integrity and public health protection, affecting life sciences companies and their securities counsel.
sec-fda-mouinter-agency-cooperationmarket-integritylife-sciences-regulationsecurities-disclosure
Read the original firm alert → Wednesday, September 2, 2026